The WFDC1 gene: Role in wound response and tissue homoeostasis

Biochemical Society Transactions

Volumn 39, Issue 5, 2011, Pages 1455-1459

  Ressler, Steven J ^a   Rowley, David R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

20 kDa prostate stromal protein (ps20); Cell adhesion; Cell proliferation; Prostate cancer; Tumour microenvironment; Whey acidic protein four disulfide core 1 (WFDC1)

Indexed keywords

20 KDA PROSTATE STROMAL PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; WHEY ACIDIC PROTEIN FOUR DISULFIDE CORE 1;

ANGIOGENESIS; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CHROMOSOME 16Q; CONFERENCE PAPER; EXON; GENE EXPRESSION; GENE MAPPING; GENE STRUCTURE; GENETIC ANALYSIS; HUMAN; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; TISSUE REPAIR; VIRUS INFECTIVITY; WOUND HEALING;

HOMEOSTASIS; HUMANS; MALE; MILK PROTEINS; PROSTATE; PROTEINS; WOUND HEALING;

EID: 80053371255     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0391455     Document Type: Conference Paper

References (46)

1. Hennighausen, L.G. and Sippel, A.E. (1982) Mouse whey acidic protein is a novel member of the family of 'four-disulfide core' proteins. Nucleic Acids Res. 10, 2677-2684
2. Rowley, D.R. and Tindall, D.J. (1987) Responses of NBT-II bladder carcinoma cells to conditioned medium from normal fetal urogenital sinus. Cancer Res. 47, 2955-2960 (Pubitemid 17113442)
3. Rowley, D.R. (1992) Characterization of a fetal urogenital sinus mesenchymal cell line U4F: secretion of a negative growth regulatory activity. In Vitro Cell Dev. Biol. 28, 29-38
4. Rowley, D.R., Dang, T.D., Larsen, M., Gerdes, M.J., McBride, L. and Lu, B. (1995) Purification of a novel protein (ps20) from urogenital sinus mesenchymal cells with growth inhibitory properties in vitro. J. Biol. Chem. 270, 22058-22065
5. 2 Microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor B1 action. Cancer Res. 55, 781-786
6. Larsen, M., Ressler, S.J., Lu, B., Gerdes, M.J., McBride, L., Dang, T.D. and Rowley, D.R. (1998) Molecular cloning and expression of ps20 growth inhibitor: a novel WAP-type 'four-disulfide core' domain protein expressed in smooth muscle. J. Biol. Chem. 273, 4574-4584 (Pubitemid 28103200)
7. Larsen, M., Ressler, S.J., Gerdes, M.J., Lu, B., Byron, M., Lawrence, J.B. and Rowley, D.R. (2000) The WFDC1 gene encoding ps20 localizes to 16q24, a region of LOH in multiple cancers. Mamm. Genome 11, 767-773
8. Watson, J.E., Doggett, N.A., Albertson, D.G., Andaya, A., Chinnaiyan, A., van Dekken, H., Ginzinger, D., Haqq, C., James, K., Kamkar, S. et al. (2004) Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer. Oncogene 23, 3487-3494 (Pubitemid 38669839)
9. McAlhany, S.J., Ayala, G.E., Frolov, A., Ressler, S.J., Wheeler, T.M., Watson, J.E., Collins, C. and Rowley, D.R. (2004) Decreased stromal expression and increased epithelial expression of WFDC1/ps20 in prostate cancer is associated with reduced recurrence-free survival. Prostate 61, 182-191 (Pubitemid 39244705)
10. Watson, J.E., Kamkar, S., James, K., Kowbel, D., Andaya, A., Paris, P.L., Simko, J., Carroll, P., McAlhany, S., Rowley, D. and Collins, C. (2004) Molecular analysis of WFDC1/ps20 gene in prostate cancer. Prostate 61, 192-199 (Pubitemid 39244706)
11. Saffroy, R., Riou, P., Soler, G., Azoulay, D., Emile, J.F., Debuire, B. and Lemoine, A. (2002) Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinoma. Eur. J. Hum. Genet. 10, 239-244 (Pubitemid 34662091)
12. Kurose, K., Gilley, K., Matsumoto, S., Watson, P.H., Zhou, X.P. and Eng, C. (2002) Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat. Genet. 32, 355-357 (Pubitemid 35266108)
13. Gratias, S., Rieder, H., Ullmann, R., Klein-Hitpass, L., Schneider, S., Boloni, R., Kappler, M. and Lohmann, D.R. (2007) Allelic loss in a minimal region on chromosome 16q24 is associated with vitreous seeding of retinoblastoma. Cancer Res. 67, 408-416 (Pubitemid 46142800)
14. Tuxhorn, J.A., Ayala, G.E., Smith, M.J., Smith, V.C., Dang, T.D. and Rowley, D.R. (2002) Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin. Cancer Res. 8, 2912-2923 (Pubitemid 35025739)
15. Tuxhorn, J.A., Ayala, G.E. and Rowley, D.R. (2001) Reactive stroma in prostate cancer progression. J. Urol. 166, 2472-2483 (Pubitemid 33065339)
16. Yang, F., Tuxhorn, J.A., Ressler, S.J., McAlhany, S.J., Dang, T.D. and Rowley, D.R. (2005) Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res. 65, 8887-8895 (Pubitemid 41377378)
17. Yang, F., Strand, D.W. and Rowley, D.R. (2008) Fibroblast growth factor-2 mediates transforming growth factor-β action in prostate cancer reactive stroma. Oncogene 27, 450-459
18. Tuxhorn, J.A., McAlhany, S.J., Yang, F., Dang, T.D. and Rowley, D.R. (2002) Inhibition of TGF-β activity decreases angiogenesis in a human prostate cancer reactive stroma xenograft model. Cancer Res. 62, 6021-6025 (Pubitemid 35244446)
19. Tuxhorn, J.A., McAlhany, S.J., Dang, T.D., Ayala, G.E. and Rowley, D.R. (2002) Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res. 62, 3298-3307 (Pubitemid 34602428)
20. McAlhany, S.J., Ressler, S.J., Larsen, M., Tuxhorn, J.A., Yang, F., Dang, T.D. and Rowley, D.R. (2003) Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model. Cancer Res. 63, 5859-5865 (Pubitemid 37187485)
21. Hurle, B., Swanson, W. and Green, E.D. (2007) Comparative sequence analyses reveal rapid and divergent evolutionary changes of the WFDC locus in the primate lineage. Genome Res. 17, 276-286 (Pubitemid 46376736)
22. Ferreira, Z., Hurle, B., Rocha, J. and Seixas, S. (2011) Differing evolutionary histories of WFDC8 (short-term balancing) in Europeans and SPINT4 (incomplete selective sweep) in Africans. Mol. Biol. Evol., doi:10.1093/molbev/ msr106
23. Bouchard, D., Morisset, D., Bourbonnais, Y. and Tremblay, G.M. (2006) Proteins with whey-acidic-protein motifs and cancer. Lancet Oncol. 7, 167-174 (Pubitemid 43159503)
24. Hellstrom, I., Raycraft, J., Hayden-Ledbetter, M., Ledbetter, J.A., Schummer, M., McIntosh, M., Drescher, C., Urban, N. and Hellstrom, K.E. (2003) The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res. 63, 3695-3700 (Pubitemid 36793054)
25. Hellstrom, I., Heagerty, P.J., Swisher, E.M., Liu, P., Jaffar, J., Agnew, K. and Hellstrom, K.E. (2010) Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms. Cancer Lett. 296, 43-48
26. Clauss, A., Ng, V., Liu, J., Piao, H., Russo, M., Vena, N., Sheng, Q., Hirsch, M.S., Bonome, T., Matulonis, U. et al. (2010) Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor κB pathway and is associated with poor overall survival. Neoplasia 12, 161-72
27. Madar, S., Brosh, R., Buganim, Y., Ezra, O., Goldstein, I., Solomon, H., Kogan, I., Goldfinger, N., Klocker, H. and Rotter, V. (2009) Modulated expression of WFDC1 during carcinogenesis and cellular senescence. Carcinogenesis 30, 20-27
28. Hung, H. (2005) Suppression of ps20 expression in the rat uterus by tamoxifen and estrogens. Endocrinology 146, 2388-2396
29. Liu, S., Ren, S., Howell, P., Fodstad, O. and Riker, A.I. (2008) Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling. Pigment Cell Melanoma Res. 21, 545-558
30. Liu, S., Howell, P., Ren, S., Fodstad, O., Zhang, G., Samant, R., Shevde, L., Xi, Y., Pannell, L.K. and Riker, A.I. (2009) Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma. Clin. Exp. Metastasis 26, 739-749
31. Li, Y., Basang, Z., Ding, H., Lu, Z., Ning, T., Wei, H., Cai, H. and Ke, Y. (2011) Latexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential. BMC Cancer 11, 121
32. Briggs, F.B., Ramsay, P.P., Madden, E., Norris, J.M., Holers, V.M., Mikuls, T.R., Sokka, T., Seldin, M.F., Gregersen, P.K., Criswell, L.A. and Barcellos, L.F. (2010) Supervised machine learning and logistic regression identifies novel epistatic risk factors with PTPN22 for rheumatoid arthritis. Genes Immun. 11, 199-208
33. Alvarez, R.A., Thorborn, G., Reading, J.L., Kamu Reddy, S. and Vyakarnam, A. (2011) WFDC1 expression identifies memory CD4 T-lymphocytes rendered vulnerable to cell-cell HIV-1 transfer by promoting intercellular adhesive junctions. Retrovirology 8, 29
34. +memory T cells that promotes infection by upregulating CD54 integrin expression and is elevated in HIV type 1 infection. J. Virol. 82, 471-486
35. Bingle, C.D. and Vyakarnam, A. (2008) Novel innate immune functions of the whey acidic protein family. Trends Immunol. 29, 444-453
36. van Soest, S.S., De Wit, G.M., Essing, A.H., ten Brink, J.B., Kamphuis, W., De Jong, P.T. and Bergen, A.A. (2007) Comparison of human retinal pigment epithelium gene expression in macula and periphery highlights potential topographic differences in Bruch's membrane. Mol. Vision 13, 1608-1617 (Pubitemid 47484606)
37. Radeke, M.J., Peterson, K.E., Johnson, L.V. and Anderson, D.H. (2007) Disease susceptibility of the human macula: differential gene transcription in the retinal pigmented epithelium/choroid. Exp. Eye Res. 85, 366-380 (Pubitemid 47259054)
38. Abbasi, A.R., Khalaj, M., Tsuji, T., Tanahara, M., Uchida, K., Sugimoto, Y. and Kunieda, T. (2009) A mutation of the WFDC1 gene is responsible for multiple ocular defects in cattle. Genomics 94, 55-62
39. Hu, Y., Guimond, S.E., Travers, P., Cadman, S., Hohenester, E., Turnbull, J.E., Kim, S.H. and Bouloux, P.M. (2009) Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1. J. Biol. Chem. 284, 29905-29920
40. Ayari, B. and Soussi-Yanicostas, N. (2007) FGFR1 and anosmin-1 underlying genetically distinct forms of Kallmann syndrome are co-expressed and interact in olfactory bulbs. Dev. Genes Evol. 217, 169-175 (Pubitemid 46206509)
41. Murcia-Belmonte, V., Esteban, P.F., Garcia-Gonzalez, D. and De Castro, F. (2010) Biochemical dissection of Anosmin-1 interaction with FGFR1 and components of the extracellular matrix. J. Neurochem. 115, 1256-1265
42. Garcia-Gonzalez, D., Clemente, D., Coelho, M., Esteban, P.F., Soussi-Yanicostas, N. and De Castro, F. (2010) Dynamic roles of FGF-2 and Anosmin-1 in the migration of neuronal precursors from the subventricular zone during pre- and postnatal development. Exp. Neurol. 222, 285-295
43. Gianola, S., De Castro, F. and Rossi, F. (2009) Anosmin-1 stimulates outgrowth and branching of developing Purkinje axons. Neuroscience 158, 570-584
44. Tengara, S., Tominaga, M., Kamo, A., Taneda, K., Negi, O., Ogawa, H. and Takamori, K. (2010) Keratinocyte-derived anosmin-1, an extracellular glycoprotein encoded by the X-linked Kallmann syndrome gene, is involved in modulation of epidermal nerve density in atopic dermatitis. J. Dermatol. Sci. 58, 64-71
45. Jian, B., Nagineni, C.N., Meleth, S., Grizzle, W., Bland, K., Chaudry, I. and Raju, R. (2009) Anosmin-1 involved in neuronal cell migration is hypoxia inducible and cancer regulated. Cell Cycle 8, 3770-3776
46. Bribian, A., Esteban, P.F., Clemente, D., Soussi-Yanicostas, N., Thomas, J.L., Zalc, B. and De Castro, F. (2008) A novel role for anosmin-1 in the adhesion and migration of oligodendrocyte precursors. Dev. Neurobiol. 68, 1503-1516